The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception
Open accessAbstract
BACKGROUND: The avoidance of menstruation through continuous or extended (greater than 28 days) administration of combination hormonal contraceptives (CHCs) has gained legitimacy through its use in treating endometriosis, dysmenorrhea, and menstruation-associated symptoms. Avoidance of menstruation through extended or continuous use of CHCs for reasons of personal preference may have additional advantages to women, including improved compliance, greater satisfaction, fewer menstrual symptoms, and less menstruation-related absenteeism from work or school. OBJECTIVES: To determine the differences between continuous or extended-cycle CHCs (pills, patch, ring) in regimens of greater than 28 days of active hormone compared with traditional cyclic dosing (21 days of active hormone and 7 days of placebo, or 24 days of active hormones and 4 days of placebo). Our hypothesis was that continuous or extended-cycle CHCs have equivalent efficacy and safety but improved bleeding profiles, amenorrhea rates, adherence, continuation, participant satisfaction, and menstrual symptoms compared with standard cyclic CHCs. SEARCH METHODS: We searched computerized databases (Cochrane Central Register of Controlled Trials, PUBMED, EMBASE, POPLINE, LILACS) for trials using continuous or extended CHCs (oral contraceptives, contraceptive ring and patch) during the years 1966 to 2013. We also searched the references in review articles and publications identified for inclusion in the protocol. Investigators were contacted regarding additional references. SELECTION CRITERIA: All randomized controlled trials in any language comparing continuous or extended-cycle (greater than 28 days of active hormones) versus traditional cyclic administration (21 days of active hormones and 7 days of placebo, or 24 days of active hormones and 4 days of placebo) of CHCs for contraception. DATA COLLECTION AND ANALYSIS: Titles and abstracts identified from the literature searches were assessed for potential inclusion. Data were extracted onto data collection forms and then entered into RevMan 5. Peto odds ratios with 95% confidence intervals were calculated for all outcomes for dichotomous outcomes. Weighted mean difference was calculated for continuous outcomes. The trials were critically appraised by examining the following factors: study design, blinding, randomization method, group allocation concealment, exclusions after randomization, loss to follow-up, and early discontinuation. Because the included trials did not have a standard treatment (type of CHC formulation, route of delivery, or time length for continuous dosing), we could not aggregate data into meta-analysis. MAIN RESULTS: Twelve randomized controlled trials met our inclusion criteria. Study findings were similar between 28-day and extended or continuous regimens in regard to contraceptive efficacy (i.e., pregnancy rates) and safety profiles. When compliance was reported, no difference between 28-day and extended or continuous cycles was found. Participants reported high satisfaction with both dosing regimens, but this was not an outcome universally studied. Overall discontinuation and discontinuation for bleeding problems were not uniformly higher in either group. The studies that reported menstrual symptoms found that the extended or continuous group fared better in terms of headaches, genital irritation, tiredness, bloating, and menstrual pain. Eleven out of the twelve studies found that bleeding patterns were either equivalent between groups or improved with extended or continuous cycles over time. Endometrial lining assessments by ultrasound and/or endometrial biopsy were done in some participants and were all normal after cyclic or extended CHC use. AUTHORS' CONCLUSIONS: The 2014 update yielded four additional trials but unchanged conclusions. Evidence from existing randomized control trials comparing continuous or extended-cycle CHCs (greater than 28 days of active combined hormones) to traditional cyclic dosing (21 days of active hormone and 7 days of placebo, or 24 days of active hormone and 4 days of placebo) is of good quality. However, the variations in type of hormones and time length for extended-cycle dosing make a formal meta-analysis impossible. Future studies should choose a previously described type of CHC and dosing regimen. More attention needs to be directed towards participant satisfaction, continuation, and menstruation-associated symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Clinical Gynecologic Endocrinology and Infertility
Speroff, & Siefer (2000) · Cited by 468
Vercellini, P., Frontino, G., De Giorgi, O., Pietropaolo, G., Pasin, R., & Crosignani, P. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00794-5 · Cited by 289
Hormone withdrawal symptoms in oral contraceptive users
Sulak, P. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(99)00524-4 · Cited by 274
A multicenter, randomized study of an extended cycle oral contraceptive
Anderson, F. D., & Hait, H. (2003) · Contraception · doi:10.1016/s0010-7824(03)00141-0 · Cited by 258
Work loss associated with increased menstrual loss in the United States
Côté, I. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02094-x · Cited by 247
The analysis of vaginal bleeding patterns induced by fertility regulating methods
Belsey, E. M., Machines, D., & d'Arcangues, C. (1986) · Contraception · doi:10.1016/0010-7824(86)90006-5 · Cited by 246
Seracchioli, R., Mabrouk, M., Frascà, C., Manuzzi, L., Montanari, G., Keramyda, A., & Venturoli, S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.052 · Cited by 228
Vercellini, P., De Giorgi, O., Mosconi, P., Stellato, G., Vicentini, S., & Crosignani, P. G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02951-x · Cited by 180
Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial
Miller, L. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00014-0 · Cited by 180
Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms
SULAK, P., CRESSMAN, B., WALDROP, E., HOLLEMAN, S., & KUEHL, T. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(96)00488-7 · Cited by 173
Nuisance or natural and healthy: should monthly menstruation be optional for women?
Thomas, S. L., & Ellertson, C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11159-0 · Cited by 172
den Tonkelaar, I., & Oddens, B. J. (1999) · Contraception · doi:10.1016/s0010-7824(99)00043-8 · Cited by 169
Loudon, N. B., Foxwell, M., Potts, D. M., Guild, A. L., & Short, R. V. (1977) · BMJ · doi:10.1136/bmj.2.6085.487 · Cited by 149
Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results
Archer, D. F., Jensen, J. T., Johnson, J. V., Borisute, H., Grubb, G. S., & Constantine, G. D. (2006) · Contraception · doi:10.1016/j.contraception.2006.07.005 · Cited by 145
Kwiecien, M., Edelman, A. B., Nichols, M. D. N., & Jensen, J. T. (2003) · Contraception · doi:10.1016/s0010-7824(02)00445-6 · Cited by 133
Self-citationMiller, L. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01555-1 · Cited by 127
Extended Regimens of the Contraceptive Vaginal Ring
Miller, L., Verhoeven, C., & Hout, J. I. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000175144.08035.74 · Cited by 124
Suvisaari, J. V. J., & Lähteenmäki, P. (1996) · Contraception · doi:10.1016/s0010-7824(96)00189-8 · Cited by 123
Coutinho, E. M., & Segal, S. J. (1999) · doi:10.1093/oso/9780195130218.001.0001 · Cited by 115
Schlaff, W. D., Lynch, A. M., Hughes, H. D., Cedars, M. I., & Smith, D. L. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.02.012 · Cited by 111
Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives
Wiegratz, I., Hommel, H. H., Zimmermann, T. P., & Kühl, H. (2004) · Contraception · doi:10.1016/j.contraception.2003.09.004 · Cited by 111
Effects of Continuous Versus Cyclical Oral Contraception: A Randomized Controlled Trial
Legro, R. S., Pauli, J. G., Kunselman, A. R., Meadows, J. W., Kesner, J. S., Zaino, R. J., Demers, L. M., Gnatuk, C. L., & Dodson, W. C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2287 · Cited by 93
Long-interval treatment regimen with a desogestrel-containing oral contraceptive
Cachrimanidou, A.-C., Hellberg, D., Nilsson, S., Waldenström, U., Olsson, S., & Sikström, B. (1993) · Contraception · doi:10.1016/0010-7824(93)80141-h · Cited by 89
Mishell, D. R., Guillebaud, J., Westhoff, C. L., Nelson, A. L., Kaunitz, A. M., Trussell, J., & Davis, A. J. (2006) · Contraception · doi:10.1016/j.contraception.2006.08.012 · Cited by 87
Anderson, F. D., Gibbons, W. E., & Portman, D. J. (2005) · Contraception · doi:10.1016/j.contraception.2005.09.010 · Cited by 82
Sulak, P. J., Smith, V., Coffee, A. L., Witt, I., Kuehl, A. L., & Kuehl, T. J. (2008) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181842071 · Cited by 81
Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use
Birtch, R. L., Olatunbosun, O. A., & Pierson, R. A. (2005) · Contraception · doi:10.1016/j.contraception.2005.09.009 · Cited by 72
Continuous Compared With Cyclic Oral Contraceptives for the Treatment of Primary Dysmenorrhea
Dmitrović, R., Kunselman, A. R., & Legro, R. S. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318257217a · Cited by 59
Sulak, P. J., Carl, J., Gopalakrishnan, I., Coffee, A. L., & Kuehl, T. J. (2004) · Contraception · doi:10.1016/j.contraception.2004.04.007 · Cited by 55
Cheewadhanaraks, S., Choksuchat, C., Dhanaworavibul, K., & Liabsuetrakul, T. (2012) · Gynecologic and Obstetric Investigation · doi:10.1159/000337713 · Cited by 54
Continuous Oral Contraceptives
Edelman, A. B., Koontz, S. L., Nichols, M. D. N., & Jensen, J. T. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000199950.64545.16 · Cited by 53
Self-citationJensen, J. T., Garie, S. G., Trummer, D., & Elliesen, J. (2012) · Contraception · doi:10.1016/j.contraception.2011.12.009 · Cited by 48
Cachrimanidou, A.-C., Hellberg, D., Nilsson, S., von Schoulz, B., Crona, N., & Siegbahn, A. (1994) · Contraception · doi:10.1016/0010-7824(94)90051-5 · Cited by 44
Machado, R. B., de Melo, N. R., & Maia, H. (2009) · Contraception · doi:10.1016/j.contraception.2009.10.010 · Cited by 42
Coutinho, E. M., O'Dwyer, E., Barbosa, I., Gu, Z., Shaaban, M. M., Aboul-Oyoon, M., & Abdel‐Aleem, H. (1995) · Contraception · doi:10.1016/0010-7824(95)00101-f · Cited by 39
Machado, R. B., Fabrini, P., Cruz, A. M., Maia, E. M. C., & Bastos, Á. D. C. (2004) · Contraception · doi:10.1016/j.contraception.2004.06.001 · Cited by 39
Machado, R. B., de Melo, N. R., Maia, H., & Cruz, A. M. (2009) · Contraception · doi:10.1016/j.contraception.2009.08.009 · Cited by 38
Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives
Hamerlynck, J. V. T. H., Vollebregt, J. A., Doornebos, C. M., & Muntendam, P. (1987) · Contraception · doi:10.1016/0010-7824(87)90022-9 · Cited by 37
Sänger, N., Stahlberg, S., Manthey, T., Mittmann, K., Mellinger, U., Lange, E., Kühl, H., & Wiegratz, I. (2008) · Contraception · doi:10.1016/j.contraception.2008.02.005 · Cited by 36
Kroll, R., Reape, K. Z., & Margolis, M. B. (2009) · Contraception · doi:10.1016/j.contraception.2009.07.003 · Cited by 35
Occurrence of menses or pregnancy after cessation of a continuous oral contraceptive
Davis, A. R., Kroll, R., Soltes, B. A., Zhang, N., Grubb, G. S., & Constantine, G. D. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.012 · Cited by 35
Johnson, J. V., Grubb, G. S., & Constantine, G. D. (2006) · Contraception · doi:10.1016/j.contraception.2006.07.009 · Cited by 31
Stephenson, J., Shawe, J., Panicker, S., Brima, N., Copas, A. J., Sauer, U., Wilkinson, C., Akintomide, H., & O’Brien, P. (2013) · Contraception · doi:10.1016/j.contraception.2013.03.014 · Cited by 28
Extended regimens of the contraceptive vaginal ring: evaluation of clinical aspects
Barreiros, F. A., Guazzelli, C. A. F., Barbosa, R. L., de Assis, F., & de Araújo, F. F. (2009) · Contraception · doi:10.1016/j.contraception.2009.10.007 · Cited by 28
Fraser, I. S., Weisberg, E., Brache, V., Alvarez, F., Massai, R., Mishell, D. R., Apter, D. L., Gale, J., Tsong, Y. Y., & Sivin, I. (2005) · Contraception · doi:10.1016/j.contraception.2004.12.015 · Cited by 28
de Voogd, W. S. (1991) · Contraception · doi:10.1016/0010-7824(91)90111-r · Cited by 28
Ruchhoft, E. A., Elkind-Hirsch, K. E., & Malinak, L. R. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58387-3 · Cited by 27
Barreiros, F. A., Guazzelli, C. A. F., Barbosa, R. L., Torloni, M. R., Barbieri, M., & Araujo, F. F. (2010) · Contraception · doi:10.1016/j.contraception.2010.11.002 · Cited by 23
Rad, M., Kluft, C., de Kam, M. L., Meijer, P., Cohen, A. F., Grubb, G. S., Constantine, G. D., & Burggraaf, J. (2011) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2011.556761 · Cited by 13
Seidman, D. S., Yeshaya, A., Ber, A., Amodai, I., Feinstein, I., Finkel, I., Gordon, N., Porat, N., Samuel, D., Shiran-Makler, E., et al. (2010) · PubMed · Cited by 12
The use of triphasic oral contraceptives in a continuous use regimen
SHULMAN, L. P. (2005) · Contraception · doi:10.1016/j.contraception.2005.02.015 · Cited by 10
SHBG (sex hormone-binding globulin)
Fortunati, N., & Catalano, M. (2012) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/45983 · Cited by 3
Cited by
Contraception Selection, Effectiveness, and Adverse Effects: A Review
Teal, S., & Edelman, A. (2021) · JAMA · doi:10.1001/jama.2021.21392 · Cited by 336
Self-citationRETIRED: No. 345-Primary Dysmenorrhea Consensus Guideline
Burnett, M., & Lemyre, M. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.12.023 · Cited by 332
LEE, C. A., CHI, C., PAVORD, S. R., BOLTON‐MAGGS, P. H. B., POLLARD, D., HINCHCLIFFE‐WOOD, A., & KADIR, R. A. (2006) · Haemophilia · doi:10.1111/j.1365-2516.2006.01314.x · Cited by 280
Estrogen-progestins and progestins for the management of endometriosis
Vercellini, P., Buggio, L., Berlanda, N., Barbara, G., Somigliana, E., & Bosari, S. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.022 · Cited by 243
Hormonal contraceptives: pharmacology tailored to women's health
De Leo, V., Musacchio, M. C., Cappelli, V., Piomboni, P., & Morgante, G. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw016 · Cited by 188
Metadata
- Authors
- Edelman, A., Micks, E., Motu’apuaka, M. L., Benson, L. S., & Stewart, F.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-07-29
- Volume
- 2023
- Issue
- 12
- Pages
- CD004695-CD004695
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2167428807
- Cited by
- 271
- References
- 54
- FWCI
- 20.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.